- Conditions
- Adenocarcinoma, Adnexal Diseases, Amyloidosis, +130 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Renal Cell Carcinoma
Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
412 public trials
75 recruiting studies
Renal Cell Carcinoma trial results
NCT07227402
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Alaska Oncology and Hematology ( Site 0133) Anchorage, Alaska, United States
- Providence Medical Foundation ( Site 0141) Fullerton, California, United States
- Cedars-Sinai Medical Center ( Site 0112) Los Angeles, California, United States
- New England Cancer Specialists ( Site 0132) Westbrook, Maine, United States
Recruiting
IDOV-Immune for Advanced Solid Tumors
NCT06910657
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- MD Anderson Cancer Center Houston, Texas, United States
- South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
- Westmead Hospital Westmead, New South Wales, Australia
NCT00001238
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
DESTINY-PANTUMOUR04
NCT07124000
- Conditions
- Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Bullhead City, Arizona, United States
- Research Site Casa Grande, Arizona, United States
- Research Site San Diego, California, United States
NCT07300241
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- NEO-811 Los Angeles Site Duarte, California, United States
- NEO-811 San Diego Site San Diego, California, United States
- NEO-811 Connecticut Site New Haven, Connecticut, United States
- NEO-811 Chicago Site Zion, Illinois, United States
NCT06047379
- Conditions
- Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
- Locations
-
- Precision NextGen Oncology Beverly Hills, California, United States
- OPN Healthcare, Inc Glendale, California, United States
- University of Southern California Los Angeles, California, United States
- MDR Core Network Boynton Beach, Florida, United States
NCT06966024
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States
NCT07049926
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States
- Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States
- Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States
Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT04981509
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States